|
|||||
|
|
Impact of platelet pathogen inactivation on blood component utilization and patient safety in a large Austrian Regional Medical Centre |
|
| Authors: | M. Amato H. Schennach M. Astl C. Y. Chen J.‐S. Lin R. J. Benjamin W. Nussbaumer |
| Affiliation: | 1. Central Institute for Blood Transfusion and Immunology, Medical University Hospital Innsbruck, Innsbruck, Austria;2. Cerus Corporation, Concord, CA, USA |
| Abstract: | |
| Keywords: | amotosalen haemovigilance INTERCEPT Blood System pathogen inactivation platelets safety |